tm
Seeing Is Believing
tm
Seeing Is Believing
Sierra Oncology's activity chart (see below) currently has 21 price targets and 16 ratings on display.
Analysts average stock forecasts to be materialized ratio is 70% with an average time for these price targets to be met of 137 days.
Most recent stock forecast was given by JAY OLSON from OPPENHEIMER on 14-Apr-2022. First documented stock forecast 23-Oct-2017.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 05-Dec-2019
$55
$0.01 (0.02%)
$45
4 years 6 months 18 days ago
(14-Apr-2022)
4/5 (80%)
$0.25 (0.46%)
442
Buy Since 23-Oct-2017
$55
$0.01 (0.02%)
$160
4 years 6 months 18 days ago
(14-Apr-2022)
0/2 (0%)
$0.25 (0.46%)
Buy Since 11-Dec-2020
$55
$0.01 (0.02%)
$51
4 years 6 months 19 days ago
(13-Apr-2022)
5/6 (83.33%)
$0.25 (0.46%)
195
Buy Since 28-Sep-2021
$39
$-15.99 (-29.08%)
4 years 11 months ago
(01-Dec-2021)
2/2 (100%)
$15.72 (67.53%)
134
What is SRRA (Sierra Oncology) average time for price targets to be met?
Which analyst most recently updated their price target on SRRA (Sierra Oncology)?
Which analyst has the most public recommendations on SRRA (Sierra Oncology)?
Which analyst is the currently most bullish on SRRA (Sierra Oncology)?
Which analyst is the currently most reserved on SRRA (Sierra Oncology)?
